{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:00:20Z","timestamp":1791306020002,"version":"4.3.1"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T00:00:00Z","timestamp":1333065600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033495","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T21:09:37Z","timestamp":1333141777000},"page":"e33495","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Characterization of the Interaction of Full-Length HIV-1 Vif Protein with its Key Regulator CBF\u03b2 and CRL5 E3 Ubiquitin Ligase Components"],"prefix":"10.1371","volume":"7","author":[{"given":"Xiaohong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chom.2008.04.008","article-title":"HIV-1 accessory proteins\u2013ensuring viral survival in a hostile environment.","volume":"3","author":"MH Malim","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.immunol.26.021607.090350","article-title":"The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.","volume":"26","author":"YL Chiu","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"ref3","first-page":"148","article-title":"Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.","volume":"8","author":"G Hache","year":"2006","journal-title":"AIDS Rev"},{"key":"ref4","first-page":"1","article-title":"Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif.","volume":"339","author":"AM Niewiadomska","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1128\/JVI.80.3.1067-1076.2006","article-title":"Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors.","volume":"80","author":"BR Cullen","year":"2006","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-4690-5-51","article-title":"HIV-1 Vif, APOBEC, and intrinsic immunity.","volume":"5","author":"R Goila-Gaur","year":"2008","journal-title":"Retrovirology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.","volume":"418","author":"AM Sheehy","year":"2002","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.78.21.11841-11852.2004","article-title":"Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.","volume":"78","author":"K Luo","year":"2004","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"12058","DOI":"10.1128\/JVI.78.21.12058-12061.2004","article-title":"APOBEC3G incorporation into human immunodeficiency virus type 1 particles.","volume":"78","author":"V Zennou","year":"2004","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"34083","DOI":"10.1074\/jbc.C400235200","article-title":"APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein.","volume":"279","author":"TM Alce","year":"2004","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2004.07.005","article-title":"HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles.","volume":"321","author":"M Douaisi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2004.08.006","article-title":"Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.","volume":"328","author":"A Schafer","year":"2004","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"33177","DOI":"10.1074\/jbc.M402062200","article-title":"The interaction between HIV-1 Gag and APOBEC3G.","volume":"279","author":"S Cen","year":"2004","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.virol.2005.01.011","article-title":"Complementary function of the two catalytic domains of APOBEC3G.","volume":"333","author":"F Navarro","year":"2005","journal-title":"Virology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.02237-06","article-title":"APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.","volume":"81","author":"A Burnett","year":"2007","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1128\/JVI.00892-07","article-title":"7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.","volume":"81","author":"T Wang","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"35822","DOI":"10.1074\/jbc.M405761200","article-title":"Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.","volume":"279","author":"ES Svarovskaia","year":"2004","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1128\/JVI.79.9.5870-5874.2005","article-title":"Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.","volume":"79","author":"MA Khan","year":"2005","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","article-title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein.","volume":"300","author":"D Lecossier","year":"2003","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.","volume":"424","author":"B Mangeat","year":"2003","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.","volume":"424","author":"H Zhang","year":"2003","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection.","volume":"113","author":"RS Harris","year":"2003","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","article-title":"Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif.","volume":"114","author":"R Mariani","year":"2003","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.","volume":"11","author":"Q Yu","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/nar\/gkh554","article-title":"APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.","volume":"32","author":"R Suspene","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.01038-06","article-title":"Inhibition of Formula-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication.","volume":"80","author":"F Guo","year":"2006","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1128\/JVI.00839-06","article-title":"Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.","volume":"80","author":"KN Bishop","year":"2006","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/JVI.00272-07","article-title":"Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration.","volume":"81","author":"JL Mbisa","year":"2007","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1128\/JVI.02584-06","article-title":"Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.","volume":"81","author":"K Luo","year":"2007","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/JVI.80.2.875-882.2006","article-title":"Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.","volume":"80","author":"SM Kaiser","year":"2006","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1128\/JVI.79.17.10978-10987.2005","article-title":"Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.","volume":"79","author":"B Schrofelbauer","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1074\/jbc.M606864200","article-title":"Virion-associated Uracil DNA Glycosylase-2 and Apurinic\/Apyrimidinic Endonuclease Are Involved in the Degradation of APOBEC3G-edited Nascent HIV-1 DNA.","volume":"282","author":"B Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virol.2007.03.022","article-title":"Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.","volume":"365","author":"Y Yang","year":"2007","journal-title":"Virology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1096\/fj.06-7241com","article-title":"Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV\/SIV Vif-like BC-box to regulate p53.","volume":"21","author":"K Luo","year":"2007","journal-title":"Faseb J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.","volume":"302","author":"X Yu","year":"2003","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1249904","article-title":"Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.","volume":"18","author":"A Mehle","year":"2004","journal-title":"Genes Dev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.","volume":"12","author":"K Stopak","year":"2003","journal-title":"Mol Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.","volume":"9","author":"M Marin","year":"2003","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","article-title":"The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.","volume":"13","author":"SG Conticello","year":"2003","journal-title":"Curr Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.","volume":"9","author":"AM Sheehy","year":"2003","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1128\/JVI.78.4.2072-2081.2004","article-title":"Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.","volume":"78","author":"B Liu","year":"2004","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1128\/JVI.79.15.9579-9587.2005","article-title":"Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB\/C E3 ubiquitin ligase.","volume":"79","author":"B Liu","year":"2005","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.","volume":"18","author":"Y Yu","year":"2004","journal-title":"Genes Dev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0502440102","article-title":"Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.","volume":"102","author":"K Luo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M602413200","article-title":"A Zinc-binding Region in Vif Binds Cul5 and Determines Cullin Selection.","volume":"281","author":"A Mehle","year":"2006","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2006.02.002","article-title":"Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.","volume":"349","author":"Z Xiao","year":"2006","journal-title":"Virology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jmb.2007.07.029","article-title":"Characterization of a Novel Cullin5 Binding Domain in HIV-1 Vif.","volume":"373","author":"Z Xiao","year":"2007","journal-title":"J Mol Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.ppat.0010006","article-title":"Natural variation in Vif: differential impact on APOBEC3G\/3F and a potential role in HIV-1 diversification.","volume":"1","author":"V Simon","year":"2005","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/JVI.80.6.3112-3115.2006","article-title":"Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.","volume":"80","author":"C Tian","year":"2006","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1128\/JVI.00388-06","article-title":"Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.","volume":"80","author":"B Schrofelbauer","year":"2006","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.00395-07","article-title":"Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.","volume":"81","author":"RA Russell","year":"2007","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"13235","DOI":"10.1128\/JVI.00204-07","article-title":"Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.","volume":"81","author":"A Mehle","year":"2007","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.virol.2007.10.017","article-title":"HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes.","volume":"372","author":"R Goila-Gaur","year":"2008","journal-title":"Virology"},{"key":"ref54","article-title":"Differential Sensitivity of \u201cOld\u201d versus \u201cNew\u201d APOBEC3G to Human Immunodeficiency Virus Type-1 Vif.","author":"R Goila-Gaur","year":"2008","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jmb.2008.06.061","article-title":"Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.","volume":"381","author":"Z He","year":"2008","journal-title":"J Mol Biol"},{"key":"ref56","article-title":"A patch of positively charged amino acids surrounding the HIV-1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.","author":"G Chen","year":"2009","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1462-5822.2008.01157.x","article-title":"Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.","volume":"10","author":"W Zhang","year":"2008","journal-title":"Cell Microbiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e3963","DOI":"10.1371\/journal.pone.0003963","article-title":"Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.","volume":"3","author":"W Zhang","year":"2008","journal-title":"PLoS ONE"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1128\/JVI.00767-08","article-title":"Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly.","volume":"82","author":"BJ Stanley","year":"2008","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/protein\/gzp004","article-title":"The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state.","volume":"22","author":"TH Reingewertz","year":"2009","journal-title":"Protein Eng Des Sel"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/bip.21209","article-title":"Conformational analysis of a peptide approximating the HCCH motif in HIV-1 Vif.","volume":"92","author":"K Giri","year":"2009","journal-title":"Biopolymers"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1021\/bi900677w","article-title":"Molecular structure and biochemical properties of the HCCH-Zn2+ site in HIV-1 Vif.","volume":"48","author":"K Giri","year":"2009","journal-title":"Biochemistry"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1128\/JVI.00031-10","article-title":"Dissection of the HIV Vif interaction with human E3 ubiquitin ligase.","volume":"84","author":"LS Wolfe","year":"2010","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e1000925","DOI":"10.1371\/journal.ppat.1000925","article-title":"The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.","volume":"6","author":"JR Bergeron","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00726-010-0725-x","article-title":"Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor.","volume":"40","author":"D Gallerano","year":"2011","journal-title":"Amino Acids"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmb.2010.08.026","article-title":"Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.","volume":"402","author":"SR Marcsisin","year":"2010","journal-title":"J Mol Biol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/157016208783885056","article-title":"Advances in the structural understanding of Vif proteins.","volume":"6","author":"P Barraud","year":"2008","journal-title":"Curr HIV Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jmb.2011.04.053","article-title":"On the solution conformation and dynamics of the HIV-1 viral infectivity factor.","volume":"410","author":"SR Marcsisin","year":"2011","journal-title":"J Mol Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1074\/jbc.271.17.10121","article-title":"Phosphorylation of Vif and its role in HIV-1 replication.","volume":"271","author":"X Yang","year":"1996","journal-title":"J Biol Chem"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/nar\/gkq979","article-title":"Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif.","volume":"39","author":"S Bernacchi","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-4-1","article-title":"Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli.","volume":"4","author":"HP Sorensen","year":"2005","journal-title":"Microb Cell Fact"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature10718","article-title":"T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction.","volume":"481","author":"W Zhang","year":"2012","journal-title":"Nature"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature10693","article-title":"Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection.","volume":"481","author":"S Jager","year":"2012","journal-title":"Nature"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature10719","article-title":"Global landscape of HIV-human protein complexes.","volume":"481","author":"S Jager","year":"2012","journal-title":"Nature"},{"key":"ref75","article-title":"Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFbeta to Degrade APOBEC3 Restriction Factors.","author":"JF Hultquist","year":"2011","journal-title":"J Virol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0921-8777(95)00040-2","article-title":"Isolation of a cDNA encoding a UV-damaged DNA binding factor defective in xeroderma pigmentosum group E cells.","volume":"362","author":"BJ Hwang","year":"1996","journal-title":"Mutat Res"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0888-7543(95)80177-N","article-title":"Structure of the leukemia-associated human CBFB gene.","volume":"26","author":"A Hajra","year":"1995","journal-title":"Genomics"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1074\/jbc.273.4.2480","article-title":"Overexpression, purification, and biophysical characterization of the heterodimerization domain of the core-binding factor beta subunit.","volume":"273","author":"X Huang","year":"1998","journal-title":"J Biol Chem"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1128\/JVI.74.18.8252-8261.2000","article-title":"Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.","volume":"74","author":"H Zhang","year":"2000","journal-title":"J Virol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/JVI.75.16.7252-7265.2001","article-title":"Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.","volume":"75","author":"MA Khan","year":"2001","journal-title":"J Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"26361","DOI":"10.1074\/jbc.M703122200","article-title":"RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.","volume":"282","author":"S Bernacchi","year":"2007","journal-title":"J Biol Chem"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1128\/JVI.74.19.8938-8945.2000","article-title":"Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.","volume":"74","author":"M Dettenhofer","year":"2000","journal-title":"J Virol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1038\/sj.onc.1207763","article-title":"Core-binding factors in hematopoiesis and immune function.","volume":"23","author":"MF de Bruijn","year":"2004","journal-title":"Oncogene"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0065-230X(07)99002-8","article-title":"RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.","volume":"99","author":"Y Ito","year":"2008","journal-title":"Adv Cancer Res"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/092986610791498876","article-title":"Structural disorder in the HIV-1 Vif protein and interaction-dependent gain of structure.","volume":"17","author":"TH Reingewertz","year":"2010","journal-title":"Protein Pept Lett"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/86264","article-title":"The leukemia-associated AML1 (Runx1)\u2013CBF beta complex functions as a DNA-induced molecular clamp.","volume":"8","author":"J Bravo","year":"2001","journal-title":"Nat Struct Biol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1074\/jbc.M004895200","article-title":"The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle.","volume":"276","author":"S Yang","year":"2001","journal-title":"J Biol Chem"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1074\/jbc.M210164200","article-title":"Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.","volume":"278","author":"B Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1742-4690-4-81","article-title":"The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.","volume":"4","author":"JH Miller","year":"2007","journal-title":"Retrovirology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/prot.21471","article-title":"Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.","volume":"69","author":"JR Auclair","year":"2007","journal-title":"Proteins"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:34:03Z","timestamp":1588973643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033495"}},"subtitle":[],"editor":[{"given":"Shibo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033495","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]}}}